miscsubjectsAI governance
Evidence review

PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-chemo-neuropathy`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-chemo-neuropathy

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-chemo-neuropathy/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. You are reading about Chemotherapy-induced neuropathy (CIPN) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Gabapentin / pregabalin matters for you

  1. Drug: Gabapentin / pregabalin
  2. What it does: Masks neuropathic pain signal; does not repair nerve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 4

Quantified confidence (this ledger): 0.33 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder (source s1)

Review of bremelanotide mechanism and approval data; no mention of neuropathy applications.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Gabapentinoids for chemotherapy-induced peripheral neuropathy (source s2)

2024 meta-analysis showing inconsistent results for gabapentinoids in CIPN.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Bremelanotide: Uses, Interactions, Mechanism of Action (source s3)

Confirms central melanocortin mechanism.

Evidence type: Published research.

What people say on Reddit

Effectiveness of ARA-290...My Assessment — Reddit, r/smallfiberneuropathy (source s4)

User comment distinguishing PT-141 from pain-focused peptides.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Neuropathy (general) · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 4 sources · swipe →chain dfbd76cb8ad6 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment.
sources: s2
mechanistic
Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves.
sources: s2
humanlow confidence
No human clinical trials have tested PT-141 for CIPN.
sources: s1
mechanisticlow confidence
PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways.
sources: s3
anecdotallow confidence
Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief.
sources: s4
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:20
PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review · 5 claims · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Chemo Neuropathy
Slug: pt-141-chemo-neuropathy
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"Chemotherapy-induced neuropathy (CIPN)","condition_key":"chemo-neuropathy","primary_peptide":"pt-141","peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":["gabapentin-lyrica"],"weight_sensitive":false,"stimulant_context":false,"break
it output
{
  "slug": "pt-141-chemo-neuropathy",
  "title": "PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review",
  "body": "## What's breaking down if you have Chemotherapy-induced neuropathy (CIPN)\n\nChemotherapy-induced peripheral neuropathy develops when certain chemo agents damage peripheral nerves. Sensory fibers often suffer first, producing numbness, tingling, burning pain, or loss of sensation in hands and feet. Motor involvement can follow with weakness or balance issues. Autonomic nerves may also be affected. The core process is axon degeneration and demyelination that outpaces natural repair mechanisms. Once nerves are damaged, symptoms can persist months or years after treatment ends. No approved therapy reverses the underlying nerve injury; management focuses on symptom control.\n\n## Why PT-141 might help you\n\n1. You are reading about **Chemotherapy-induced neuropathy (CIPN)** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system on pathways linked to arousal and desire. If your CIPN includes central sensitization or sexual function disruption from nerve damage, the compound's CNS effects are the relevant 
e4c746e3457ab142
Machine verification: /api/articles/pt-141-chemo-neuropathy/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "A 2024 meta-analysis found limited and inconsistent evidence for gabapentinoids in CIPN prevention and treatment."?
ask pt-141-chemo-neuropathy claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Gabapentin/pregabalin suppresses neuropathic pain signals without repairing nerves."?
ask pt-141-chemo-neuropathy claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials have tested PT-141 for CIPN."?
ask pt-141-chemo-neuropathy claim c1 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 acts as a melanocortin receptor agonist primarily affecting central arousal pathways."?
ask pt-141-chemo-neuropathy claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit anecdotes mention PT-141 in neuropathy contexts only in passing and note its sexual-arousal focus rather than pain relief."?
ask pt-141-chemo-neuropathy claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User comment distinguishing PT-141 from pain-focused peptides."
ask pt-141-chemo-neuropathy source s4 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review — and what would you need me to tell you first?
ask pt-141-chemo-neuropathy condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Chemotherapy-Induced Neuropathy: Evidence Review (studies vs anecdotes)?
ask pt-141-chemo-neuropathy good bad experiences · paste includes §SELF
pt-141-chemo-neuropathy · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 26771 tokens · $0 · 2 models
chain head 9800b2ce322032f1
write grok/grok-4.3 · 2026-06-30 01:20 · 26771 tok · 02b14ca9275d
voxel_divide owner · 2026-07-17 02:41 · tokens unrecorded · 9800b2ce3220
verify chain →
Live ledger · 13 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 08:52
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 08:26
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 06:31
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 05:32
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 05:31
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 04:59
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-chemo-neuropathy · GET /api/articles/pt-141-chemo-neuropathy?format=post (the editable body)
create/replace POST /api/articles/pt-141-chemo-neuropathy · PUT /api/articles/pt-141-chemo-neuropathy (replace, keeps revision) · PATCH /api/articles/pt-141-chemo-neuropathy (merge)
delete DELETE /api/articles/pt-141-chemo-neuropathy
writes need header x-terminal-key
LLM bundle GET /api/articles/pt-141-chemo-neuropathy/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim pt-141-chemo-neuropathy|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →